The Identification and Genetic Characterization of Parechovirus Infection Among Pediatric Patients With Wide Clinical Spectrum in Chongqing, China

• DOI: 10.3389/fmicb.2021.709849
• Publication Date: 2021-09-14T14:56:44Z
• Authors: Xiao-Ai Zhang; Rui-Qiu Zhao; Jin-Jin Chen; Yang Yuan; Xiang Tang; Zi-Wei Zhou; Luo Ren; Qin-Bin Lu; Yu-Na Wang; Hai-Yang Zhang; Pan-He Zhang; Li-Qun Fang; Hai-Sheng Zhou; En-Mei Liu; Hong-Mei Xu; Wei Liu
• Keywords: Diarrhea; Genotype; Epidemiology; hand foot and mouth disease; Pathogenesis; Cluster (spacecraft); FOS: Health sciences; Microbiology; Gene; 03 medical and health sciences; respiratory infection; Virology; Health Sciences; Epidemiology and Pathogenesis of Respiratory Viral Infections; Genetics; Aetiology, Diagnosis, and Management of Myocarditis; parechovirus; Internal medicine; Biology; Enterovirus; 0303 health sciences; Gastroenterology; acute diarrhea; Gastrointestinal Viral Infections and Vaccines Development; Computer science; QR1-502; Virus; Programming language; 3. Good health; Infectious Diseases; FOS: Biological sciences; Medicine; epidemiology; Cardiology and Cardiovascular Medicine

Human parechoviruses (HPeVs) are important causes of infection in children. However, without a comprehensive and persistent surveillance, the epidemiology and clinical features of HPeV infection remain ambiguous. We performed a hospital-based surveillance study among three groups of pediatric patients with acute respiratory infection (Group 1), acute diarrhea (Group 2), and hand, foot and mouth disease (Group 3) in Chongqing, China, from 2009 to 2015. Among 10,212 tested patients, 707 (6.92%) were positive for HPeV, with the positive rates differing significantly among three groups (Group 1, 3.43%; Group 2, 14.94%; Group 3, 3.55%; P < 0.001). The co-infection with other pathogens was detected in 75.2% (531/707) of HPeV-positive patients. Significant negative interaction between HPeV and Parainfluenza virus (PIV) (P = 0.046, OR = 0.59, 95% CI = 0.34–0.98) and positive interactions between HPeV and Enterovirus (EV) (P = 0.015, OR = 2.28, 95% CI = 1.23–4.73) were identified. Among 707 HPeV-positive patients, 592 (83.73%) were successfully sequenced, and 10 genotypes were identified, with HPeV1 (n = 396), HPeV4 (n = 86), and HPeV3 (n = 46) as the most frequently seen. The proportion of genotypes differed among three groups (P < 0.001), with HPeV1 and HPeV4 overrepresented in Group 2 and HPeV6 overrepresented in Group 3. The spatial patterns of HPeV genotypes disclosed more close clustering of the currently sequenced strains than those from other countries/regions, although they were indeed mixed. Three main genotypes (HPeV1, HPeV3, and HPeV4) had shown distinct seasonal peaks, highlighting a bi-annual cycle of all HpeV and two genotypes (HPeV 1 and HPeV 4) with peaks in odd-numbered years and with peaks in even-numbered years HPeV3. Significantly higher HPeV1 viral loads were associated with severe diarrhea in Group 2 (P = 0.044), while associated with HPeV single infection than HPeV-EV coinfection among HFMD patients (P = 0.001). It’s concluded that HPeV infection was correlated with wide clinical spectrum in pediatric patients with a high variety of genotypes determined. Still no clinical significance can be confirmed, which warranted more molecular surveillance in the future.